DK128674B - Fremgangsmåde til fremstilling af tabletter indeholdende vandopløselige salte af α-carboxyester-substituerede phenylmethyl-penicilliner eller α-carboxyester-substituerede phenylmethyl-cephalosporiner til oral indgivning. - Google Patents

Fremgangsmåde til fremstilling af tabletter indeholdende vandopløselige salte af α-carboxyester-substituerede phenylmethyl-penicilliner eller α-carboxyester-substituerede phenylmethyl-cephalosporiner til oral indgivning.

Info

Publication number
DK128674B
DK128674B DK138070AA DK138070A DK128674B DK 128674 B DK128674 B DK 128674B DK 138070A A DK138070A A DK 138070AA DK 138070 A DK138070 A DK 138070A DK 128674 B DK128674 B DK 128674B
Authority
DK
Denmark
Prior art keywords
carboxyester
substituted phenylmethyl
penicillins
cephalosporins
preparation
Prior art date
Application number
DK138070AA
Other languages
Danish (da)
English (en)
Inventor
J Dwight
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of DK128674B publication Critical patent/DK128674B/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • A61K31/429Thiazoles condensed with heterocyclic ring systems
    • A61K31/43Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2009Inorganic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
DK138070AA 1969-03-20 1970-03-19 Fremgangsmåde til fremstilling af tabletter indeholdende vandopløselige salte af α-carboxyester-substituerede phenylmethyl-penicilliner eller α-carboxyester-substituerede phenylmethyl-cephalosporiner til oral indgivning. DK128674B (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB04670/69A GB1291281A (en) 1969-03-20 1969-03-20 Improvements in pharmaceutical compositions

Publications (1)

Publication Number Publication Date
DK128674B true DK128674B (da) 1974-06-17

Family

ID=10045462

Family Applications (1)

Application Number Title Priority Date Filing Date
DK138070AA DK128674B (da) 1969-03-20 1970-03-19 Fremgangsmåde til fremstilling af tabletter indeholdende vandopløselige salte af α-carboxyester-substituerede phenylmethyl-penicilliner eller α-carboxyester-substituerede phenylmethyl-cephalosporiner til oral indgivning.

Country Status (10)

Country Link
BE (1) BE747656A (fr)
DE (1) DE2013039A1 (fr)
DK (1) DK128674B (fr)
ES (1) ES377725A1 (fr)
FI (1) FI51653C (fr)
FR (1) FR2035118B1 (fr)
GB (1) GB1291281A (fr)
IL (1) IL34089A (fr)
NL (1) NL143419B (fr)
SE (1) SE379284B (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2083622B1 (fr) * 1970-03-27 1975-08-22 Sankyo Co
US3969524A (en) * 1974-08-13 1976-07-13 Hoffmann-La Roche Inc. Stable amoxicillin dosage form
JPS5329936A (en) * 1976-08-31 1978-03-20 Takeda Chem Ind Ltd Antibiotic composition
EP0012495B1 (fr) * 1978-12-08 1983-06-22 Beecham Group Plc Composition pharmaceutique comprenant un sel hydrosoluble d'amoxycilline et polyvinylpyrrolidone, et une ampoule contenant une dose unitaire de cette composition
CA2061520C (fr) * 1991-03-27 2003-04-22 Lawrence J. Daher Systeme de delivrance accelerant l'effet et accroissant la puissance

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2438106A (en) * 1944-06-09 1948-03-23 Wyeth Corp Peroral penicillin compositions
US2864744A (en) * 1955-09-02 1958-12-16 American Home Prod Penicillin in solid dosage unit form
US3131123A (en) * 1959-03-13 1964-04-28 Lab Francais De Therapeutique Enteric tablets and manufacture thereof
GB1276839A (en) * 1968-08-02 1972-06-07 Sandoz Products Ltd Antibiotic compositions

Also Published As

Publication number Publication date
FI51653B (fr) 1976-11-30
GB1291281A (en) 1972-10-04
NL143419B (nl) 1974-10-15
FR2035118B1 (fr) 1974-08-30
IL34089A (en) 1974-05-16
IL34089A0 (en) 1970-05-21
FI51653C (fi) 1977-03-10
DE2013039A1 (de) 1970-09-24
NL7004004A (fr) 1970-09-22
SE379284B (fr) 1975-10-06
BE747656A (fr) 1970-09-21
FR2035118A1 (fr) 1970-12-18
ES377725A1 (es) 1972-10-16

Similar Documents

Publication Publication Date Title
DK128053B (da) Fremgangsmåde til fremstilling af farmaceutiske kapsler af hydroxyalkylalkylcelluloseethere.
DK139869B (da) Analogifremgangsmåde til fremstilling af phenyl-imidazolyl-alkansyrederivater eller salte deraf.
DK132172C (da) Analogifremgangsmade til fremstilling af 6,7-benzomorphaner eller salte deraf
DK124031B (da) Analogifremgangsmåde til fremstilling af fenylsubstituerede piperazinylalkylaminouraciler, -uracilætere eller -uraciltioætere eller salte deraf.
DK135278B (da) Analogifremgangsmåde til fremstilling af fenoksyisopropanolaminderivater eller syreadditionssalte deraf.
DK138424B (da) Analogifremgangsmåde til fremstilling af 5-oxopyrido(2,3-d)pyrimidin-6-carboxylsyre-derivater.
DK126788B (da) Analogifremgangsmåde til fremstilling af γ-morpholino-p-amino-butyrophenoner eller salte deraf.
DK129650B (da) Analogifremgangsmåde til fremstilling af 1-phenoxy-2-hydroxy-3-amino-propaner eller salte deraf.
DK118301B (da) Fremgangsmåde til fremstilling af antitussive præparater, som indeholder dextromethorphan eller et salt deraf.
DK128052B (da) Fremgangsmåde til fremstilling af enhedsdoser i fast tilstand af lægemidler under anvendelse af sukker som bærestof.
DK128674B (da) Fremgangsmåde til fremstilling af tabletter indeholdende vandopløselige salte af α-carboxyester-substituerede phenylmethyl-penicilliner eller α-carboxyester-substituerede phenylmethyl-cephalosporiner til oral indgivning.
DK123708B (da) Fremgangsmåde til fremstilling af polyencarboxylsyrer eller salte deraf.
DK125245B (da) Fremgangsmåde til fremstilling af γpiperidinobutyrophenonderivater eller syreadditionssalte deraf.
DK128496B (da) Fremgangsmåde til fremstilling af 5-fluoruracilderivater.
DK125472B (da) Analogifremgangsmåde til fremstilling af pyrimidopyridazinderivater eller syreadditionssalte deraf.
DK126203B (da) Analogifremgangsmåde til fremstilling af thiophenddikesyrederivater.
DK135835B (da) Analogifremgangsmåde til fremstilling af substituerede alkensyrederivater eller salte deraf.
DK138490B (da) Fremgangsmåde til fremstilling af prostadiensyrederivater.
DK131374B (da) Fremgangsmåde til fremstilling af 1,4-benzodiazepinderivater eller salte deraf.
DK123527B (da) Fremgangsmåde til fremstilling af lumilysergsyrederivater.
DK124885B (da) Analogifremgangsmåde til fremstilling af 4-alkenyl-substituerede 1,2-difenyl-3,5-dioxopyrazolidiner eller salte heraf.
DK126201B (da) Analogifremgangsmåde til fremstilling af 1,4-benzodiazepinderivater eller salte deraf.
DK134235B (da) Fremgangsmåde til fremstilling af salte af alfa-D-glucose-1-phosphorsyre.
DK127878B (da) Analogifremgangsmåde til fremstilling af 1-amino-3-phenoxy-2-propanolderivater eller salte deraf.
DK136364B (da) Analogifremgangsmåde til fremstilling af 4(5)-trifluormethylimidazolderivater eller salte deraf.

Legal Events

Date Code Title Description
PBP Patent lapsed